Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dalton

Showing results (21-30 of 375) with videos related to

Pageof 38
Sort By:
Oncology (Williston Park, N.Y.)|February 4, 2005
Proteasome inhibition in hematologic malignancies: clinical update and practical applicationsWilliam S Dalton
Seminars in Oncology|August 1, 1990
Mechanisms of drug resistance in breast cancerW S Dalton
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
The tumor microenvironment as a determinant of drug response and resistanceWilliam S. Dalton
Current Opinion in Oncology|November 1, 1994
Is p-glycoprotein a potential target for reversing clinical drug resistance?W S Dalton
Seminars in Oncology|April 1, 2005
The proteasomeWilliam S Dalton
Current Opinion in Oncology|December 1, 1991
Clinical and laboratory approaches to drug resistanceW S Dalton
Leukemia|July 1, 1997
Detection of multidrug resistance gene expression in multiple myelomaW S Dalton
Molecular and Cellular Biology|October 7, 1997
Characterization of Cdc47p-minichromosome maintenance complexes in Saccharomyces cerevisiae: identification of Cdc45p as a subunitS Dalton, B Hopwood
Cell|February 7, 1992
Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response elementS Dalton, R Treisman
Cell|January 28, 1994
Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response elementS Dalton, R Treisman
Pageof 38

Showing results (21-30 of 375) with videos related to

Sort By:
Pageof 38
Oncology (Williston Park, N.Y.)|February 4, 2005
Proteasome inhibition in hematologic malignancies: clinical update and practical applicationsWilliam S Dalton
Seminars in Oncology|August 1, 1990
Mechanisms of drug resistance in breast cancerW S Dalton
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
The tumor microenvironment as a determinant of drug response and resistanceWilliam S. Dalton
Current Opinion in Oncology|November 1, 1994
Is p-glycoprotein a potential target for reversing clinical drug resistance?W S Dalton
Seminars in Oncology|April 1, 2005
The proteasomeWilliam S Dalton
Current Opinion in Oncology|December 1, 1991
Clinical and laboratory approaches to drug resistanceW S Dalton
Leukemia|July 1, 1997
Detection of multidrug resistance gene expression in multiple myelomaW S Dalton
Molecular and Cellular Biology|October 7, 1997
Characterization of Cdc47p-minichromosome maintenance complexes in Saccharomyces cerevisiae: identification of Cdc45p as a subunitS Dalton, B Hopwood
Cell|February 7, 1992
Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response elementS Dalton, R Treisman
Cell|January 28, 1994
Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response elementS Dalton, R Treisman
Pageof 38